Global medical tourism is evolving beyond self-pay travel into structured, institutionally driven healthcare mobility. Multinational employers, global insurers, TPAs, and sovereign health buyers are increasingly exploring cross-border solutions for complex procedures, specialty pharmaceuticals, and executive health programs—but scaling these models requires infrastructure, transparency, and risk alignment.

‍

This session examines how institutional buyers, global payers, AI integration, longevity medicine, and structured partnerships are reshaping international patient mobility. We will explore the shift from transactional referrals to coordinated domestic and international Centers of Excellence, the role of technology in enabling scalable growth, and the emerging payment and risk frameworks necessary for enterprise adoption.

‍

This discussion sets the strategic direction for the next decade of global healthcare mobility.